Summary COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of
symptom severity that requires varying amounts of care according to the different stages of …

Non-steroidal anti-inflammatory drugs (NSAIDs) are a class of medications that are routinely
been used across the world. Their analgesic, anti-inflammatory, and antipyretic effects have …

Abstract Coronavirus disease 2019 (COVID-19) is especially severe in aged populations.
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …

Background Nonsteroidal anti-inflammatory drugs (NSAIDs) have been discouraged for the
treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections …

Early in the COVID-19 pandemic, anecdotal reports emerged suggesting non-steroidal anti-
inflammatory drugs (NSAIDs) may increase susceptibility to infection and adversely impact …

Objectives To describe the rates for consulting a general practitioner (GP) for sequelae after
acute covid-19 in patients admitted to hospital with covid-19 and those managed in the …

В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …

Acute inflammation is a critical host defense response during viral infection. When
dysregulated, inflammation drives immunopathology and tissue damage. Excessive …

At the start of the coronavirus disease 2019 (COVID-19) pandemic (March 2020), there was
speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, used to …

Background Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce
pain, fever, and inflammation but have been associated with complications in community …